Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax · last filed 2026-07-30

  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2026-06-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2026-03-31 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2025-03-31 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for the quarter ending 2024-12-31 was $6.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2025 was $18.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2024 was -$16.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2023 was -$25.00M, a 200.00% decline from fiscal 2022.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax for fiscal 2022 was $25.00M, a 37.50% decline from fiscal 2021.
Period endOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 3 monthOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 3 month as first filedOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 6 monthOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 6 month as first filedOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 9 monthOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 9 month as first filedOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 12 monthOther Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-07-30
$0.00
10-Q · filed 2026-07-30
2026-03-31$0.00
10-Q · filed 2026-04-30
2025-12-31$18.00M
10-K · filed 2026-02-11
2025-03-31$0.00
10-Q · filed 2026-04-30
$6.00M
derived: sum of 2 quarters · filed 2026-04-30
$6.00M
derived: sum of 3 quarters · filed 2026-04-30
-$15.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$6.00M
derived: sum of 2 quarters · filed 2026-02-11
-$15.00M
derived: sum of 3 quarters · filed 2026-02-11
-$16.00M
10-K · filed 2026-02-11
2024-09-30$0.00
10-Q · filed 2024-10-31
-$21.00M
derived: sum of 2 quarters · filed 2024-10-31
-$22.00M
10-Q · filed 2024-10-31
-$46.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30-$21.00M
10-Q · filed 2024-07-26
-$22.00M
10-Q · filed 2024-07-26
-$46.00M
derived: sum of 3 quarters · filed 2026-02-11
-$45.00M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31-$1.00M
10-Q · filed 2025-04-24
-$25.00M
derived: sum of 2 quarters · filed 2026-02-11
-$24.00M
derived: sum of 3 quarters · filed 2026-02-11
-$26.00M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31-$24.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$23.00M
derived: sum of 2 quarters · filed 2026-02-11
-$25.00M
derived: sum of 3 quarters · filed 2026-02-11
-$25.00M
10-K · filed 2026-02-11
2023-09-30$1.00M
10-Q · filed 2024-10-31
-$1.00M
derived: sum of 2 quarters · filed 2024-10-31
-$1.00M
10-Q · filed 2024-10-31
$13.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30-$2.00M
10-Q · filed 2024-07-26
-$2.00M
10-Q · filed 2024-07-26
$12.00M
derived: sum of 3 quarters · filed 2025-02-12
$16.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$0.00
10-Q · filed 2024-04-25
$14.00M
derived: sum of 2 quarters · filed 2025-02-12
$18.00M
derived: sum of 3 quarters · filed 2025-02-12
$21.00M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$18.00M
derived: sum of 2 quarters · filed 2025-02-12
$21.00M
derived: sum of 3 quarters · filed 2025-02-12
$25.00M
10-K · filed 2025-02-12
2022-09-30$4.00M
10-Q · filed 2023-10-26
$7.00M
derived: sum of 2 quarters · filed 2023-10-26
$11.00M
10-Q · filed 2023-10-26
$49.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30$3.00M
10-Q · filed 2023-07-27
$7.00M
10-Q · filed 2023-07-27
$45.00M
derived: sum of 3 quarters · filed 2024-02-13
$44.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31$4.00M
10-Q · filed 2023-04-27
$42.00M
derived: sum of 2 quarters · filed 2024-02-13
$41.00M
derived: sum of 3 quarters · filed 2024-02-13
$39.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31$38.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
$37.00M
derived: sum of 2 quarters · filed 2024-02-13
$35.00M
derived: sum of 3 quarters · filed 2024-02-13
$40.00M
10-K · filed 2024-02-13
2021-09-30-$1.00M
10-Q · filed 2022-10-26
-$3.00M
derived: sum of 2 quarters · filed 2022-10-26
$2.00M
10-Q · filed 2022-10-26
-$17.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$2.00M
10-Q · filed 2022-07-27
$3.00M
10-Q · filed 2022-07-27
-$16.00M
derived: sum of 3 quarters · filed 2023-02-14
-$19.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31$5.00M
10-Q · filed 2022-04-29
-$14.00M
derived: sum of 2 quarters · filed 2023-02-14
-$17.00M
derived: sum of 3 quarters · filed 2023-02-14
-$22.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$19.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$22.00M
derived: sum of 2 quarters · filed 2023-02-14
-$27.00M
derived: sum of 3 quarters · filed 2023-02-14
-$25.00M
10-K · filed 2023-02-14
2020-09-30-$3.00M
10-Q · filed 2021-10-27
-$8.00M
derived: sum of 2 quarters · filed 2021-10-27
-$6.00M
10-Q · filed 2021-10-27
-$4.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30-$5.00M
10-Q · filed 2021-07-28
-$3.00M
10-Q · filed 2021-07-28
-$1.00M
derived: sum of 3 quarters · filed 2022-02-09
-$28.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31$2.00M
10-Q · filed 2021-04-29
$4.00M
derived: sum of 2 quarters · filed 2022-02-09
-$23.00M
derived: sum of 3 quarters · filed 2022-02-09
-$26.00M
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
-$25.00M
derived: sum of 2 quarters · filed 2022-02-09
-$28.00M
derived: sum of 3 quarters · filed 2022-02-09
-$28.00M
10-K · filed 2022-02-09
2019-09-30-$27.00M
10-Q · filed 2020-11-05
-$30.00M
derived: sum of 2 quarters · filed 2020-11-05
-$30.00M
10-Q · filed 2020-11-05
-$48.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30-$3.00M
10-Q · filed 2020-08-06
-$3.00M
10-Q · filed 2020-08-06
-$21.00M
derived: sum of 3 quarters · filed 2021-02-10
-$24.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$0.00
10-Q · filed 2020-05-07
-$18.00M
derived: sum of 2 quarters · filed 2021-02-10
-$21.00M
derived: sum of 3 quarters · filed 2021-02-10
-$21.00M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31-$18.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
-$21.00M
derived: sum of 2 quarters · filed 2021-02-10
-$21.00M
derived: sum of 3 quarters · filed 2021-02-10
$3.00M
10-K · filed 2021-02-10
2018-09-30-$3.00M
10-Q · filed 2019-10-31
$3.00M
10-Q · filed 2018-10-25
-$3.00M
derived: sum of 2 quarters · filed 2019-10-31
$21.00M
10-Q · filed 2019-10-31
-$21.00M
10-Q · filed 2018-10-25
-$7.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$0.00
10-Q · filed 2019-07-25
$24.00M
10-Q · filed 2019-07-25
-$24.00M
10-Q · filed 2018-07-26
-$4.00M
derived: sum of 3 quarters · filed 2020-02-24
-$2.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$24.00M
10-Q · filed 2019-04-25
-$24.00M
10-Q · filed 2018-04-26
-$4.00M
derived: sum of 2 quarters · filed 2020-02-24
-$2.00M
derived: sum of 3 quarters · filed 2020-02-24
$31.00M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31-$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$26.00M
derived: sum of 2 quarters · filed 2020-02-24
$7.00M
derived: sum of 3 quarters · filed 2020-02-24
-$11.00M
10-K · filed 2020-02-24
$11.00M
10-K · filed 2018-02-13
2017-09-30$2.00M
10-Q · filed 2018-10-25
$35.00M
derived: sum of 2 quarters · filed 2018-10-25
$17.00M
10-Q · filed 2018-10-25
-$140.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30$33.00M
10-Q · filed 2018-07-26
$15.00M
10-Q · filed 2018-07-26
-$142.00M
derived: sum of 3 quarters · filed 2019-02-25
-$168.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$18.00M
10-Q · filed 2018-04-26
-$175.00M
derived: sum of 2 quarters · filed 2019-02-25
-$201.00M
derived: sum of 3 quarters · filed 2019-02-25
-$118.00M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31-$157.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
-$183.00M
derived: sum of 2 quarters · filed 2019-02-25
-$100.00M
derived: sum of 3 quarters · filed 2019-02-25
$3.00M
10-K · filed 2019-02-25
-$3.00M
10-K · filed 2017-02-21
2016-09-30-$26.00M
10-Q · filed 2017-10-26
$57.00M
derived: sum of 2 quarters · filed 2017-10-26
$160.00M
10-Q · filed 2017-10-26
$194.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30$83.00M
10-Q · filed 2017-07-27
$186.00M
10-Q · filed 2017-07-27
$220.00M
derived: sum of 3 quarters · filed 2018-02-13
$316.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31$103.00M
10-Q · filed 2017-04-27
$137.00M
derived: sum of 2 quarters · filed 2018-02-13
$233.00M
derived: sum of 3 quarters · filed 2018-02-13
$88.00M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$130.00M
derived: sum of 2 quarters · filed 2018-02-13
-$15.00M
derived: sum of 3 quarters · filed 2018-02-13
$27.00M
10-K · filed 2018-02-13
2015-09-30$96.00M
10-Q · filed 2016-10-27
-$49.00M
derived: sum of 2 quarters · filed 2016-10-27
-$7.00M
10-Q · filed 2016-10-27
$118.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-06-30-$145.00M
10-Q · filed 2016-07-28
-$103.00M
10-Q · filed 2016-07-28
$22.00M
derived: sum of 3 quarters · filed 2017-02-21
$258.00M
derived: sum of 4 quarters · filed 2017-02-21
2015-03-31$42.00M
10-Q · filed 2016-04-28
$167.00M
derived: sum of 2 quarters · filed 2017-02-21
$403.00M
derived: sum of 3 quarters · filed 2017-02-21
$416.00M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31$125.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
$361.00M
derived: sum of 2 quarters · filed 2017-02-21
$374.00M
derived: sum of 3 quarters · filed 2017-02-21
$464.00M
10-K · filed 2017-02-21
2014-09-30$236.00M
10-Q · filed 2015-10-27
$249.00M
derived: sum of 2 quarters · filed 2015-10-27
$339.00M
10-Q · filed 2015-10-27
$246.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30$13.00M
10-Q · filed 2015-07-23
$103.00M
10-Q · filed 2015-07-23
$10.00M
derived: sum of 3 quarters · filed 2016-02-12
-$71.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31$90.00M
10-Q · filed 2015-04-28
-$3.00M
derived: sum of 2 quarters · filed 2016-02-12
-$84.00M
derived: sum of 3 quarters · filed 2016-02-12
-$414.00M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31-$93.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$174.00M
derived: sum of 2 quarters · filed 2016-02-12
-$504.00M
derived: sum of 3 quarters · filed 2016-02-12
-$504.00M
10-K · filed 2016-02-12
2013-09-30-$81.00M
10-Q · filed 2014-10-24
-$411.00M
derived: sum of 2 quarters · filed 2014-10-24
-$411.00M
10-Q · filed 2014-10-24
2013-06-30-$330.00M
10-Q · filed 2014-07-24
-$330.00M
10-Q · filed 2014-07-24
2012-12-31$126.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
$126.00M
derived: sum of 2 quarters · filed 2015-02-13
$126.00M
derived: sum of 3 quarters · filed 2015-02-13
$121.00M
10-K · filed 2015-02-13
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
-$5.00M
10-Q · filed 2013-10-23
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25
-$5.00M
10-Q · filed 2013-07-25
2012-03-31-$5.00M
10-Q · filed 2013-04-25
2011-12-31$421.00M
10-K · filed 2014-02-14
2010-12-31$62.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$62.00M
derived: sum of 2 quarters · filed 2013-02-15
$66.00M
derived: sum of 3 quarters · filed 2013-02-15
$66.00M
10-K · filed 2013-02-15
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
$4.00M
derived: sum of 2 quarters · filed 2011-10-27
$4.00M
10-Q · filed 2011-10-27
2010-06-30$4.00M
10-Q · filed 2011-07-28
$4.00M
10-Q · filed 2011-07-28
2009-12-31$41.00M
10-K · filed 2012-02-17
2008-12-31$697.00M
10-K · filed 2011-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64